ES2062006T3 - Un psti humano modificado. - Google Patents

Un psti humano modificado.

Info

Publication number
ES2062006T3
ES2062006T3 ES89307309T ES89307309T ES2062006T3 ES 2062006 T3 ES2062006 T3 ES 2062006T3 ES 89307309 T ES89307309 T ES 89307309T ES 89307309 T ES89307309 T ES 89307309T ES 2062006 T3 ES2062006 T3 ES 2062006T3
Authority
ES
Spain
Prior art keywords
modified human
human psti
dna sequences
psti
asur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89307309T
Other languages
English (en)
Inventor
Nobuo Yoshida
Norihisa Kikuchi
Hiroshi Teraoka
Masaru Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2062006T3 publication Critical patent/ES2062006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/845—Pancreas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SECUENCIAS DE DNA, QUE CODIFICAN VARIEDADES MODIFICADAS DE PSTI HUMANO, TIENEN EXCELENTE ESTABILIDAD EN EL SENTIDO DE SUSCEPTIBILIDAD DISMINUIDA A LA DESCOMPOSICION POR ENZIMAS PROTEOLITICOS, TALES COMO TRIPSINA, EN COMPARACION CON PSTI HUMANO NATURAL, ASI COMO LAS VARIEDADES MODIFICADAS DE PSTI HUMANO OBTENIDAS POR LA EXPRESION DE DICHAS SECUENCIAS DE DNA.
ES89307309T 1988-07-19 1989-07-19 Un psti humano modificado. Expired - Lifetime ES2062006T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18131688 1988-07-19
JP63255580A JPH07102137B2 (ja) 1988-07-19 1988-10-11 修飾ヒトｐｓｔｉ

Publications (1)

Publication Number Publication Date
ES2062006T3 true ES2062006T3 (es) 1994-12-16

Family

ID=26500552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89307309T Expired - Lifetime ES2062006T3 (es) 1988-07-19 1989-07-19 Un psti humano modificado.

Country Status (8)

Country Link
US (1) US5122594A (es)
EP (1) EP0352089B1 (es)
JP (1) JPH07102137B2 (es)
KR (1) KR960015745B1 (es)
AU (1) AU612865B2 (es)
CA (1) CA1339875C (es)
DE (1) DE68913090T2 (es)
ES (1) ES2062006T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
US5231010A (en) * 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
JPH0751066B2 (ja) * 1990-09-14 1995-06-05 重三 鵜高 プロテアーゼインヒビター遺伝子及び該遺伝子を保有する微生物並びに該微生物を用いるプロテアーゼインヒビターの製造法
IL104314A0 (en) * 1992-01-07 1993-05-13 Novo Nordisk As Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
JP3626982B2 (ja) * 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
ES2753183T3 (es) * 2007-02-12 2020-04-07 Csl Behring Gmbh Aplicación terapéutica de inhibidores de la proteasa de serina de tipo Kazal
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059340T3 (es) * 1986-10-14 1994-11-16 Shionogi & Co Un metodo de preparacion de proteinas.
JPS63267289A (ja) * 1986-10-14 1988-11-04 Shionogi & Co Ltd 蛋白質の新規製法
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor

Also Published As

Publication number Publication date
US5122594A (en) 1992-06-16
DE68913090T2 (de) 1994-05-26
EP0352089A2 (en) 1990-01-24
EP0352089B1 (en) 1994-02-16
JPH07102137B2 (ja) 1995-11-08
AU612865B2 (en) 1991-07-18
DE68913090D1 (de) 1994-03-24
KR960015745B1 (ko) 1996-11-20
JPH02150282A (ja) 1990-06-08
EP0352089A3 (en) 1990-08-16
AU3797889A (en) 1990-01-25
CA1339875C (en) 1998-05-19
KR900001853A (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2135411T3 (es) Proteinas osp a de subgrupos de borrelia burgdorferi, genes codificantes y vacunas.
ES2163864T3 (es) Secuencias de dna de 2-desoxiglucosa-6-fosfato (2-dog-6-p) como marcador de seleccion en plantas.
ATE119941T1 (de) Subtilisin-analoge.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
DK0471754T3 (da) Produktion af vaskulær endotelcelle vækstfaktor, samt DNA kodende for denne
ES2061632T5 (es) Kluyveromyces como celula hospedante.
DK288183D0 (da) Fremgangsmade til fremstilling af et oligonucleotidt terapeutisk middel
ES2094111T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion que utilizan celulas modificadas por ingenieria genetica y composiciones farmaceuticas que las contienen.
ES2001152A4 (es) Preparados cosmeticos a base de n - hidroxibutil - quitosanas, nuevasn - hidroxibutil - quitosanas, asi como el procedimiento para su obtencion.
ES2082003T3 (es) Deshidrodidemnina b.
FR2762850B1 (fr) Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations
ES2119411T3 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
ES2076160T3 (es) Analogos de las subunidades de la toxina de bordetella obtenidos a partir de adn recombinante.
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
ES2062006T3 (es) Un psti humano modificado.
ES2125426T3 (es) Composicion a base de esteres de c12 a c20 y utilizacion en el desmaquillaje.
NO179754C (no) Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekveks som koder for t-PA-analogen, ekspresjonsvektor omfattende DNA-sekvensen samt vertscelle omfattende denne
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
ES2092263T3 (es) Analogos de la 15-deoxispergualina, su metodo de preparacion y su utilizacion en terapeutica como agentes inmunosupresores.
ES2185671T3 (es) Depsipeptidos ciclicos que contienen acido lactico con 18 atomos en el anillo como agentes endoparasticidas y procedimiento para su obtencion.
ES2181695T3 (es) Vacuna recombinante contra la pleuroneumonia porcina.
ES2142490T3 (es) Ciclopeptolidos.
DE69534470T2 (de) Lgmd- gen kodierend für eine calcium-abhängige protease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 352089

Country of ref document: ES